Pleural fluid soluble Fas ligand and tuberculous pleural effusion: a prospective diagnostic test accuracy study

Xu-Hui Wen1,2, Jian-Xun Wen3, Lan Mu1

  • 1Department of Parasitology, The Basic Medical Sciences College of Inner Mongolia Medical University, Hohhot, China.

PubMed
Abstract

Insights

Soluble Fas ligand (sFasL) shows moderate diagnostic accuracy for tuberculous pleural effusion (TPE). While not superior to adenosine deaminase (ADA), sFasL offers a net benefit in diagnosing TPE in patients with undiagnosed pleural effusion.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Biomarker Research

Background:

  • Tuberculous pleural effusion (TPE) diagnosis is challenging.
  • Traditional markers like adenosine deaminase (ADA) have limitations.
  • Soluble Fas ligand (sFasL) shows potential for TPE diagnosis.

Purpose of the Study:

  • Evaluate the additional diagnostic value of pleural fluid sFasL for TPE.
  • Assess the net benefit of sFasL in diagnosing TPE.
  • Investigate factors influencing sFasL diagnostic accuracy.

Main Methods:

  • Prospective enrollment of 211 patients with undiagnosed pleural effusion.
  • Measurement of pleural fluid sFasL concentration using ELISA.
  • Analysis of diagnostic accuracy and net benefit using ROC curves, DCA, NRI, and IDI.

Main Results:

  • sFasL demonstrated moderate diagnostic accuracy (AUC=0.74) for TPE.
  • ADA showed higher accuracy (AUC=0.80).
  • sFasL analysis indicated a net benefit and significant improvement in reclassification (NRI=0.36, P=0.05).

Conclusions:

  • Pleural fluid sFasL has moderate diagnostic accuracy for TPE.
  • sFasL provides a net benefit in diagnosing TPE.
  • sFasL may complement traditional markers like ADA for TPE diagnosis.

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
179
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
1.0K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
332
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
239